Keyphrases
Attention Deficit Hyperactivity Disorder
84%
Netherlands
58%
Cost-effectiveness
58%
Atopic Disease
56%
Indonesia
42%
Finnish Diabetes Risk Score
35%
Confidence Interval
35%
Methylphenidate
33%
Indonesian Population
31%
Economic Evaluation
30%
Psychostimulants
28%
Diabetes Medications
28%
Statin Therapy
28%
Cost-effectiveness Analysis
28%
Pneumococcal Vaccination
28%
Non-persistence
28%
Non-adherence
28%
Tobacco
28%
Non-communicable Disease Prevention
28%
Disadvantaged Groups
28%
Implementation Research
28%
Adolescent Exposure
28%
Global Implementation
28%
Air Pollution
28%
Statins
24%
AIDS Knowledge
23%
Cost Savings
23%
Adaptation
22%
Uganda
22%
Non-communicable Diseases
21%
Odds Ratio
20%
Systematic Meta-analysis
19%
Psychostimulant Drugs
18%
Vaccination
18%
Utility Score
18%
Health-related Quality of Life
18%
Asthma
17%
Attention Deficit Hyperactivity Disorder Medication
17%
Allergic Rhinitis
17%
Dutch
16%
Indonesian
16%
Tobacco Use
16%
Rapid Review
16%
Kidney Disease Quality of life-36
16%
Diabetes
16%
Pharmacy
15%
School Performance
15%
New User
15%
Asian Countries
14%
Nortriptyline
14%
Medicine and Dentistry
Health Care Cost
100%
Cost-Effectiveness Analysis
93%
Systematic Review
57%
Wart Virus
56%
Cervical Cancer
53%
Cervical Cancer Screening
48%
Diabetes
44%
Prophylaxis
42%
Non Communicable Disease
42%
Cross Sectional Study
32%
Screening
32%
Quality of Life
30%
Adolescent Exposure
28%
Acetic Acid
27%
Household
23%
Symptom
21%
Prevalence
19%
Low and Middle Income Countries
19%
Quality Adjusted Life Year
18%
Tobacco Use
16%
Health Survey
15%
Randomized Controlled Trial
15%
Pneumococcus Vaccine
14%
Attention Deficit Disorder
14%
Methylphenidate
14%
Nortriptyline
14%
Cancer Therapy
14%
Typical Antipsychotic
14%
Arm
14%
Infection
14%
Drug Therapy
14%
CYP2D6
14%
Breast Cancer
14%
Mammography
14%
COVID-19 Vaccination
14%
Observational Study
14%
Chronic Kidney Disease
14%
Pancreas Cancer
14%
Psychometry
14%
Nephropathy
14%
Consumer
14%
Venlafaxine
14%
Rotavirus Vaccine
14%
Evaluation Study
14%
Dysglycemia
14%
Sepsis
14%
Pharmacogenetic Testing
14%
Awareness
14%
Patient Compliance
14%
Triage
14%